07/01/2009
CAMLOG under new leadership – Dr Michael Peetz appointed as CEO
After five years of successfully heading the CAMLOG Group, Jürg Eichenberger stepped down as Chief Executive Officer of CAMLOG Biotechnologies AG, Basel/Switzerland, at the end of last year. He maintains his function as Chairman of the Board of Directors of CAMLOG Holding AG. In the years from 2003 to 2008, decisively shaped by Jürg Eichenberger, the international CAMLOG Group has continuously developed above market average.
As of January 2009, Dr Michael Peetz has been appointed new CEO of CAMLOG Biotechnologies AG. He is exceptionally experienced and qualified to succeed Jürg Eichenberger. From 1990 to 2008, Dr Peetz held important executive positions with Geistlich Pharma AG, Wolhusen/Switzerland. As a Managing Director, Chief Operating Officer, and member of the Executive Board, he led Geistlich Biomaterials into the position of the world-wide leading provider of Regenerative Products and turned this division into a profitable and internationally significant business unit.
Dr Peetz also was founder and a member of the Board of Directors of the OSTEOLOGY FOUNDATION and a member of its Scientific and Education Committees. He was the initiator of a series of world-wide recognized OSTEOLOGY congresses with more than 2,500 participants.
Headed by the new CEO, the proven CAMLOG team will continue to reinforce and expand their international market positions.
|
|
|
|
|
|
Back